The anesthetist’s choice of inhalational vs. intravenous anesthetics has no impact on survival of glioblastoma patients

Recent data suggest that the type of anesthesia used during the resection of solid tumors impacts the long-term survival of patients favoring total-intravenous-anesthesia (TIVA) over inhalative-anesthesia (INHA). Here we sought to query this impact on survival in patients undergoing resection of gli...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Schmoch, Thomas (VerfasserIn) , Jungk, Christine (VerfasserIn) , Bruckner, Thomas (VerfasserIn) , Haag, Sabine (VerfasserIn) , Zweckberger, Klaus (VerfasserIn) , Deimling, Andreas von (VerfasserIn) , Brenner, Thorsten (VerfasserIn) , Unterberg, Andreas (VerfasserIn) , Weigand, Markus A. (VerfasserIn) , Uhle, Florian (VerfasserIn) , Herold-Mende, Christel (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2021
In: Neurosurgical review
Year: 2021, Jahrgang: 44, Heft: 5, Pages: 2707-2715
ISSN:1437-2320
DOI:10.1007/s10143-020-01452-7
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s10143-020-01452-7
Verlag, kostenfrei, Volltext: https://link.springer.com/article/10.1007/s10143-020-01452-7
Volltext
Verfasserangaben:Thomas Schmoch, Christine Jungk, Thomas Bruckner, Sabine Haag, Klaus Zweckberger, Andreas von Deimling, Thorsten Brenner, Andreas Unterberg, Markus A. Weigand, Florian Uhle, Christel Herold-Mende

MARC

LEADER 00000caa a2200000 c 4500
001 1871023459
003 DE-627
005 20240307091955.0
007 cr uuu---uuuuu
008 231123s2021 xx |||||o 00| ||eng c
024 7 |a 10.1007/s10143-020-01452-7  |2 doi 
035 |a (DE-627)1871023459 
035 |a (DE-599)KXP1871023459 
035 |a (OCoLC)1425217051 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Schmoch, Thomas  |d 1985-  |e VerfasserIn  |0 (DE-588)1072523493  |0 (DE-627)827680546  |0 (DE-576)433996331  |4 aut 
245 1 4 |a The anesthetist’s choice of inhalational vs. intravenous anesthetics has no impact on survival of glioblastoma patients  |c Thomas Schmoch, Christine Jungk, Thomas Bruckner, Sabine Haag, Klaus Zweckberger, Andreas von Deimling, Thorsten Brenner, Andreas Unterberg, Markus A. Weigand, Florian Uhle, Christel Herold-Mende 
246 3 3 |a The anesthetist’s choice of inhalational versus intravenous anesthetics has no impact on survival of glioblastoma patients 
264 1 |c 2021 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Published online: 2021 
500 |a Gesehen am 23.11.2023 
520 |a Recent data suggest that the type of anesthesia used during the resection of solid tumors impacts the long-term survival of patients favoring total-intravenous-anesthesia (TIVA) over inhalative-anesthesia (INHA). Here we sought to query this impact on survival in patients undergoing resection of glioblastoma (GBM). All patients receiving elective resection of a newly diagnosed, isocitrate-dehydrogenase-1-(IDH1)-wildtype GBM under general anesthesia between January 2010 and June 2017 in the Department of Neurosurgery, Heidelberg University Hospital, were included. Patients were grouped according to the applied anesthetic technique. To adjust for potential prognostic confounders, patients were matched in a 1:2 ratio (TIVA vs. INHA), taking into account the known prognostic factors: age, extent of resection, O-6-methylguanine-DNA-methyltransferase-(MGMT)-promoter-methylation-status, pre-operative Karnofsky-performance-index and adjuvant radio- and chemotherapy. The primary endpoint was progression-free-survival (PFS) and the secondary endpoint was overall-survival (OS). In the study period, 576 patients underwent resection of a newly diagnosed, IDH-wildtype GBM. Patients with incomplete follow-up-data, on palliative treatment, having emergency or awake surgery; 54 patients remained in the TIVA-group and 417 in the INHA-group. After matching, 52 patients remained in the TIVA-group and 92 in the INHA-group. Median PFS was 6 months in both groups. The median OS was 13.5 months in the TIVA-group and 13.0 months in the INHA-group. No significant survival differences associated with the type of anesthesia were found either before or after adjustment for known prognostic factors. This retrospective study supports the notion that the current anesthetic approaches employed during the resection of IDH-wildtype GBM do not impact patient survival. 
650 4 |a Glioblastoma 
650 4 |a Inhalational anesthesia 
650 4 |a TIVA 
700 1 |a Jungk, Christine  |e VerfasserIn  |0 (DE-588)1051888247  |0 (DE-627)78696765X  |0 (DE-576)407515968  |4 aut 
700 1 |a Bruckner, Thomas  |d 1956-  |e VerfasserIn  |0 (DE-588)136046215  |0 (DE-627)574429298  |0 (DE-576)300798768  |4 aut 
700 1 |a Haag, Sabine  |e VerfasserIn  |0 (DE-588)1310941475  |0 (DE-627)187102255X  |4 aut 
700 1 |a Zweckberger, Klaus  |d 1978-  |e VerfasserIn  |0 (DE-588)13205034X  |0 (DE-627)517299534  |0 (DE-576)298915510  |4 aut 
700 1 |a Deimling, Andreas von  |d 1959-  |e VerfasserIn  |0 (DE-588)103034115X  |0 (DE-627)735093946  |0 (DE-576)378138065  |4 aut 
700 1 |a Brenner, Thorsten  |d 1978-  |e VerfasserIn  |0 (DE-588)130125709  |0 (DE-627)491713363  |0 (DE-576)189360607  |4 aut 
700 1 |a Unterberg, Andreas  |e VerfasserIn  |0 (DE-588)1032681187  |0 (DE-627)738641200  |0 (DE-576)168441233  |4 aut 
700 1 |a Weigand, Markus A.  |d 1967-  |e VerfasserIn  |0 (DE-588)1064970435  |0 (DE-627)815375239  |0 (DE-576)424658666  |4 aut 
700 1 |a Uhle, Florian  |e VerfasserIn  |0 (DE-588)106860560X  |0 (DE-627)820511730  |0 (DE-576)427922534  |4 aut 
700 1 |a Herold-Mende, Christel  |e VerfasserIn  |0 (DE-588)1022936549  |0 (DE-627)717335577  |0 (DE-576)366194267  |4 aut 
773 0 8 |i Enthalten in  |t Neurosurgical review  |d Berlin : Springer, 1978  |g 44(2021), 5 vom: Nov., Seite 2707-2715  |h Online-Ressource  |w (DE-627)269533133  |w (DE-600)1474861-7  |w (DE-576)080987060  |x 1437-2320  |7 nnas  |a The anesthetist’s choice of inhalational vs. intravenous anesthetics has no impact on survival of glioblastoma patients 
773 1 8 |g volume:44  |g year:2021  |g number:5  |g month:11  |g pages:2707-2715  |g extent:9  |a The anesthetist’s choice of inhalational vs. intravenous anesthetics has no impact on survival of glioblastoma patients 
856 4 0 |u https://doi.org/10.1007/s10143-020-01452-7  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://link.springer.com/article/10.1007/s10143-020-01452-7  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20231123 
993 |a Article 
994 |a 2021 
998 |g 1022936549  |a Herold-Mende, Christel  |m 1022936549:Herold-Mende, Christel  |d 910000  |d 911200  |e 910000PH1022936549  |e 911200PH1022936549  |k 0/910000/  |k 1/910000/911200/  |p 11  |y j 
998 |g 106860560X  |a Uhle, Florian  |m 106860560X:Uhle, Florian  |d 910000  |d 910300  |e 910000PU106860560X  |e 910300PU106860560X  |k 0/910000/  |k 1/910000/910300/  |p 10 
998 |g 1064970435  |a Weigand, Markus A.  |m 1064970435:Weigand, Markus A.  |d 910000  |d 910300  |e 910000PW1064970435  |e 910300PW1064970435  |k 0/910000/  |k 1/910000/910300/  |p 9 
998 |g 1032681187  |a Unterberg, Andreas  |m 1032681187:Unterberg, Andreas  |d 910000  |d 911200  |e 910000PU1032681187  |e 911200PU1032681187  |k 0/910000/  |k 1/910000/911200/  |p 8 
998 |g 130125709  |a Brenner, Thorsten  |m 130125709:Brenner, Thorsten  |d 50000  |e 50000PB130125709  |k 0/50000/  |p 7 
998 |g 103034115X  |a Deimling, Andreas von  |m 103034115X:Deimling, Andreas von  |d 910000  |d 912000  |e 910000PD103034115X  |e 912000PD103034115X  |k 0/910000/  |k 1/910000/912000/  |p 6 
998 |g 13205034X  |a Zweckberger, Klaus  |m 13205034X:Zweckberger, Klaus  |d 910000  |d 911200  |d 50000  |e 910000PZ13205034X  |e 911200PZ13205034X  |e 50000PZ13205034X  |k 0/910000/  |k 1/910000/911200/  |k 0/50000/  |p 5 
998 |g 1310941475  |a Haag, Sabine  |m 1310941475:Haag, Sabine  |d 910000  |d 910300  |e 910000PH1310941475  |e 910300PH1310941475  |k 0/910000/  |k 1/910000/910300/  |p 4 
998 |g 136046215  |a Bruckner, Thomas  |m 136046215:Bruckner, Thomas  |d 910000  |d 911800  |e 910000PB136046215  |e 911800PB136046215  |k 0/910000/  |k 1/910000/911800/  |p 3 
998 |g 1051888247  |a Jungk, Christine  |m 1051888247:Jungk, Christine  |d 910000  |d 911200  |d 50000  |e 910000PJ1051888247  |e 911200PJ1051888247  |e 50000PJ1051888247  |k 0/910000/  |k 1/910000/911200/  |k 0/50000/  |p 2 
998 |g 1072523493  |a Schmoch, Thomas  |m 1072523493:Schmoch, Thomas  |p 1  |x j 
999 |a KXP-PPN1871023459  |e 441652482X 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"note":["Published online: 2021","Gesehen am 23.11.2023"],"title":[{"title":"The anesthetist’s choice of inhalational vs. intravenous anesthetics has no impact on survival of glioblastoma patients","title_sort":"anesthetist’s choice of inhalational vs. intravenous anesthetics has no impact on survival of glioblastoma patients"}],"origin":[{"dateIssuedDisp":"2021","dateIssuedKey":"2021"}],"relHost":[{"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 24.11.05","Fortsetzung der Druck-Ausgabe"],"id":{"issn":["1437-2320"],"eki":["269533133"],"zdb":["1474861-7"]},"title":[{"title":"Neurosurgical review","title_sort":"Neurosurgical review"}],"part":{"text":"44(2021), 5 vom: Nov., Seite 2707-2715","extent":"9","issue":"5","pages":"2707-2715","volume":"44","year":"2021"},"origin":[{"publisher":"Springer","dateIssuedDisp":"1978-","dateIssuedKey":"1978","publisherPlace":"Berlin ; Heidelberg ; New York"}],"pubHistory":["1.1978 -"],"disp":"The anesthetist’s choice of inhalational vs. intravenous anesthetics has no impact on survival of glioblastoma patientsNeurosurgical review","physDesc":[{"extent":"Online-Ressource"}],"recId":"269533133"}],"person":[{"family":"Schmoch","role":"aut","given":"Thomas","display":"Schmoch, Thomas"},{"display":"Jungk, Christine","given":"Christine","role":"aut","family":"Jungk"},{"role":"aut","given":"Thomas","family":"Bruckner","display":"Bruckner, Thomas"},{"given":"Sabine","role":"aut","family":"Haag","display":"Haag, Sabine"},{"display":"Zweckberger, Klaus","given":"Klaus","role":"aut","family":"Zweckberger"},{"family":"Deimling","given":"Andreas von","role":"aut","display":"Deimling, Andreas von"},{"display":"Brenner, Thorsten","role":"aut","given":"Thorsten","family":"Brenner"},{"given":"Andreas","role":"aut","family":"Unterberg","display":"Unterberg, Andreas"},{"display":"Weigand, Markus A.","role":"aut","given":"Markus A.","family":"Weigand"},{"family":"Uhle","role":"aut","given":"Florian","display":"Uhle, Florian"},{"display":"Herold-Mende, Christel","role":"aut","given":"Christel","family":"Herold-Mende"}],"physDesc":[{"extent":"9 S."}],"recId":"1871023459","id":{"eki":["1871023459"],"doi":["10.1007/s10143-020-01452-7"]},"name":{"displayForm":["Thomas Schmoch, Christine Jungk, Thomas Bruckner, Sabine Haag, Klaus Zweckberger, Andreas von Deimling, Thorsten Brenner, Andreas Unterberg, Markus A. Weigand, Florian Uhle, Christel Herold-Mende"]},"titleAlt":[{"title":"The anesthetist’s choice of inhalational versus intravenous anesthetics has no impact on survival of glioblastoma patients"}]} 
SRT |a SCHMOCHTHOANESTHETIS2021